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Regulation of Trophoblast Invasion by Pyruvate Kinase
Isozyme M2 (PKM2)
Juan F. Mejia, Parker Hall, Kelsey M. Hirschi, Paul R. Reynolds, and Juan A. Arroyo.
Department of Physiology and Developmental Biology, Brigham Young University, Provo, UT

Introduction
Abnormal placentation in pregnancy may result in
complications such as preeclampsia (PE). PE is one of
the leading causes of maternal and fetal morbidity and
mortality in developed countries. This disease is
characterized by a decrease in trophoblast invasion
due to a hypoxic environment. The pyruvate kinase
isozyme M2 (PKM2) is an enzyme exclusively present
in highly proliferating cells such as in embryonic
tissues, cancer, and placental trophoblast cells. In its
active form PKM2 is phosphorylated and has an active
role in the conversion of PEP to pyruvate in the
cytosol. Inactive PKM2 is present in nuclear tissues
where it directs glycolytic intermediates for use in cell
proliferation. The role of PKM2 in PE is still unknown.
The objective of this study was to determine the
cytosolic and nuclear PKM2 expression pattern and
determine PKM2 regulation of trophoblast cell invasion
in the presence of PKM2 activator and inactivator
during normoxia or hypoxia.

Results

During normoxia we observed:
1. 2-fold increase (p<0.002) in trophoblast invasion
when PKM2 was activated by FBP6.

PKM2 Invasion (Normoxia)
Red: FBP6
Blue: Control
Green: Shikonin

2. 68-fold reduction (p<0.002) in trophoblast
invasion when PKM2 activation was inhibited by
Shikonin.
3. 1.4-fold induction (p<0.03) of nuclear PKM2 in
the trophoblast when PKM2 was activated.
4. 1.6-fold induction (p<0.04) of nuclear PKM2 after
PKM2 inactivation.

Figure 1. Trophoblast invasion and
PKM2 in normoxic conditions.
Activation of PKM2 (FBP6) increases
trophoblast invasion while PKM2
inhibition significantly decreases
invasion.

5. 1.4-fold decrease (p<0.03) in cytosolic PKM2
after PKM2 inactivation.
Figure 2. Trophoblast PKM2 protein in normoxia. PKM2 protein was
decreased in the cytosol, but increased in the nucleus with both treatments
during normoxia. Inactive p-PKM2 was decreased in the cytosol, but
increased in the nucleus when PKM2 activation was inhibited.

Real time cell invasion
Trophoblast cells were plated at a concentration of
20,000 cells/well in the presence or absence of FBP6
or Shikonin. Cells were placed in the RTCA DP
instrument and invasion readings were completed
every 5 minutes for 24 hours.
Western blot for PKM2
Placental cells were lysed in protein lysis buffer.
Nuclear and cytosolic protein extraction was
performed. Membranes were incubated overnight with
phosphorylated or total PKM2 (CellSignaling) antibody.

During hypoxia we observed:
1. 3-fold decrease (p<0.005) in cell invasion in
treated cells .
2. 1.6-fold decrease (p<0.03) in cytosolic PKM2
expression in treated cells.

Methods
Cell culture and treatments
SW71 invasive trophoblast cells were used for these
experiments. Cells were cultured in RPMI medium
supplemented with 10% fetal bovine serum (FBS), 1%
penicillin and streptomycin. Trophoblast cells were
treated with Fructose-1,6-bisphosphate (FBP6; PKM2
activator) or Shikonin (PKM2 activation inhibitor) in
normoxic and hypoxic (2% O2) conditions.

Summary

3. No significant differences in the expression of
cytosolic PKM2 with treatment.

PKM2 Invasion after HX
Red: FBP6
Blue: Control
Green: Shikonin

Statistical analysis with Mann-Whitney testing
was performed. Data is shown as mean ± SE.
P<0.05 was considered significant.

Conclusions
Figure 3. Trophoblast invasion
and PKM2 in hypoxic conditions.
A decrease in trophoblast invasion
was observed with PKM2
Activation (FBP6) or inhibition
(Shikonin) during hypoxia.

Figure 4. Trophoblast PKM2 protein and hypoxia. PKM2 protein was
increased in the cytosol when PKM2 activation was inhibited by Shikonin. A
decrease in PKM2 was observed in nuclear extract for both treatments. pPKM2 was decreased in the cytosol when PKM2 was activated, and
increased with PKM2 inactivation.

We conclude that PKM2 regulates trophoblast cell
invasion through localized allosteric activation and
inhibition. Our results suggest that phosphorylation of
PKM2 is affected by hypoxia. Furthermore, these
results suggest that PKM2 could be a mediator of
trophoblast cell invasion, and its abundance
influences the development of complicated
pregnancies like PE.

